01—Abstract
Summary
Summary of the 8-K filed May 6, 2021. Cited figures are marked; the original filing is the authoritative source.
Moderna, Inc. (MRNA) filed an 8-K on May 6, 2021, to report its first-quarter financial results for the period ended March 31, 2021.
The core of this filing is the press release furnished as Exhibit 99.1, which provides details on the company's operational and financial performance. Investors should refer to this press release for the specific financial figures and operational updates for the first quarter of 2021, as the 8-K itself primarily serves to incorporate that information by reference.
02—Key points
Key Highlights
- Moderna announced its first-quarter 2021 financial and operational results on May 6, 2021.
- The 8-K filing incorporates by reference a press release detailing these results.
- Investors need to consult the furnished press release (Exhibit 99.1) for the substantive financial information and operational updates.
- The filing confirms the disclosure of Q1 2021 results, which is critical for tracking the company's performance in the ongoing COVID-19 vaccine rollout and its broader mRNA pipeline.
- The information furnished is not considered 'filed' for the purposes of Section 18 of the Exchange Act, but is important for understanding the company's status as of the reporting date.
03—Questions
Frequently Asked Questions
What is the main purpose of this 8-K filing?
The main purpose of this 8-K filing is to formally announce and provide access to Moderna, Inc.'s financial results and operational condition for the first quarter ended March 31, 2021. It does this by incorporating a press release (Exhibit 99.1) that contains the detailed information.
Where can I find the detailed financial results for Q1 2021?
The detailed financial results and operational information for the first quarter ended March 31, 2021, are contained within the press release furnished as Exhibit 99.1 to this 8-K filing. You should refer to that document for specific numbers and commentary.
Does this filing contain new guidance or significant business updates beyond Q1 results?
This 8-K filing primarily serves to report on the past quarter's financial and operational performance as detailed in the accompanying press release. For forward-looking guidance or significant new business updates beyond what's in the Q1 press release, investors would need to review other company communications or filings.
Is the information in this 8-K considered 'filed' and subject to liability?
The filing specifies that the information furnished in this Current Report and Exhibit 99.1 is intended to be furnished, not 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934. Therefore, it is not subject to the liabilities of that section, although it still provides crucial information for investors.
04—Continue